Skip to main content

LA36 Pill - pink capsule/oblong, 20mm

Pill with imprint LA36 is Pink, Capsule/Oblong and has been identified as Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 600 mg / 200 mg / 300 mg. It is supplied by Laurus Labs Limited.

Efavirenz/emtricitabine/tenofovir is used in the treatment of Occupational Exposure; Nonoccupational Exposure; HIV Infection and belongs to the drug class antiviral combinations. There is positive evidence of human fetal risk during pregnancy. Efavirenz/emtricitabine/tenofovir 600 mg / 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LA36

Efavirenz, emtricitabine and tenofovir disoproxil fumarate 600 mg / 200 mg / 300 mg LA36

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate

Imprint
LA36
Strength
600 mg / 200 mg / 300 mg
Color
Pink
Size
20.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Laurus Labs Limited
National Drug Code (NDC)
42385-0915
Inactive Ingredients
croscarmellose sodium, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, ferrosoferric oxide, polyethylene glycol, ferric oxide red, talc, titanium dioxide, polyvinyl alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.